Literature DB >> 23743672

Effect of position of infant during phototherapy in management of hyperbilirubinemia in late preterm and term neonates: a randomized controlled trial.

S Bhethanabhotla1, A Thukral, M J Sankar, R Agarwal, V K Paul, A K Deorari.   

Abstract

OBJECTIVE: To evaluate the effect of supine position when compared with periodic change of position during phototherapy in late preterm and term neonates (35 to 42 weeks) with hyperbilirubinemia on the duration of phototherapy. STUDY
DESIGN: We randomly allocated enrolled neonates with hyperbilirubinemia to either no change in position (supine group (SG); n=54) or two-hourly change of position from supine to prone and vice versa (turning group (TG); n=46). All the infants received single surface phototherapy by two dedicated compact fluorescent light units. Total serum bilirubin (TSB) was measured at the start of phototherapy and then every 12 ± 2 h until the end of phototherapy. Phototherapy was stopped when two values were below the cut-off for age and gestational age as per the American Academy of Pediatrics Subcommittee on Hyperbilirubinemia guidelines nomogram for the management of hyperbilirubinemia in infants >35 weeks of gestation. The primary outcome was duration of phototherapy and secondary outcome was rate of fall of bilirubin within the first 24 ± 2 h after the initiation of phototherapy. RESULT: Baseline characteristics including birth weight (g, 2752 ± 478 vs 2748 ± 416 P=0.96), gestation (week, 37.1 ± 1.2 vs 37.4 ± 1.3, P=0.26) were similar in the two groups. There was no difference in the duration of phototherapy between the SG (mean ± s.d., hour, 25.5 ± 8) and TG (mean ± s.d., hour, 24.8 ± 5), mean difference (95% confidence interval), hour, 0.7 (-2.03, 3.44, P=0.6). Rate of fall of bilirubin was also similar in both supine and turning groups with mean difference of -0.020 (95% confidence interval: -0.061, 0.021, P=0.34).
CONCLUSION: Nursing babies in supine position when compared with periodic position change during phototherapy does not decrease the duration of phototherapy.

Entities:  

Mesh:

Year:  2013        PMID: 23743672     DOI: 10.1038/jp.2013.54

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  3 in total

1.  The impact of hemoglobin on the efficacy of phototherapy in hyperbilirubinemic infants.

Authors:  Mette L Donneborg; Pernille K Vandborg; Bo M Hansen; Maria Rodrigo-Domingo; Finn Ebbesen
Journal:  Pediatr Res       Date:  2017-09-06       Impact factor: 3.756

Review 2.  Periodic change of body position under phototherapy in term and preterm neonates with hyperbilirubinaemia.

Authors:  Anu Thukral; Ashok Deorari; Deepak Chawla
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

3.  Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial.

Authors:  Monica Sachdeva; Srinivas Murki; Tejo Pratap Oleti; Hemasree Kandraju
Journal:  Eur J Pediatr       Date:  2014-07-09       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.